Lisa Argnani

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 140 publications

Predictors of outcomes and satisfaction with tirbanibulin in actinic keratosis: a multicenter real-world study.

Predictors of outcomes and satisfaction with tirbanibulin in actinic keratosis: a multicenter real-world study.

Journal: Italian journal of dermatology and venereology

Published: August 24, 2026

Sarcoid-like Reactions in Hodgkin Lymphoma Treated with Pembrolizumab.

Sarcoid-like Reactions in Hodgkin Lymphoma Treated with Pembrolizumab.

Journal: Mediterranean journal of hematology and infectious diseases

Published: March 18, 2026

Analytical and clinical performance of in-house and commercial real-time PCR assays for diagnosing L. infantum visceral leishmaniasis: a study from a hub center in Northern Italy.

Analytical and clinical performance of in-house and commercial real-time PCR assays for diagnosing L. infantum visceral leishmaniasis: a study from a hub center in Northern Italy.

Journal: Journal of clinical microbiology

Published: February 13, 2026

Accuracy of percutaneous ultrasound-guided needle biopsy of abdominal lymph nodes for the diagnosis of malignant disease.

Accuracy of percutaneous ultrasound-guided needle biopsy of abdominal lymph nodes for the diagnosis of malignant disease.

Journal: Oncology letters

Published: January 22, 2026

A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma.

A Real-Life Multicenter Study of Checkpoint Inhibitors in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma.

Journal: American journal of hematology

Published: December 19, 2025

MACOP-B in Adult Langerhans Cell Histiocytosis Confirms Durable Organ Responses at an Updated Long-Term Follow-Up.

MACOP-B in Adult Langerhans Cell Histiocytosis Confirms Durable Organ Responses at an Updated Long-Term Follow-Up.

Journal: American journal of hematology

Published: December 01, 2025

Immune-related adverse events in the treatment of Hodgkin lymphoma with immune checkpoint inhibitors.

Immune-related adverse events in the treatment of Hodgkin lymphoma with immune checkpoint inhibitors.

Journal: British journal of haematology

Published: November 27, 2025

Polatuzumab vedotin-containing regimens as bridge to CART: analysis from the CART-SIE study.

Polatuzumab vedotin-containing regimens as bridge to CART: analysis from the CART-SIE study.

Journal: Blood advances

Published: October 20, 2025

Outcomes of CAR T-Cell Therapy in transformed indolent Non-Hodgkin Lymphomas and de novo DLBCL: A comparative analysis from the Italian CAR T-SIE study.

Outcomes of CAR T-Cell Therapy in transformed indolent Non-Hodgkin Lymphomas and de novo DLBCL: A comparative analysis from the Italian CAR T-SIE study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 18, 2025

TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey.

TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey.

Journal: Hematological oncology

Published: September 02, 2025

Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study).

Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study).

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: July 28, 2025

Quality and duration of responses with mogamulizumab in cutaneous T-cell lymphomas: Insights into long-lasting outcomes.

Quality and duration of responses with mogamulizumab in cutaneous T-cell lymphomas: Insights into long-lasting outcomes.

Journal: British journal of haematology

Published: June 11, 2025

Showing 1-12 of 140

Last Updated: 09/26/2026